Addiction Practice Changes in the COVID Era and New ASAM Clinical Guidelines
During these unprecedented and trying times, information is coming at us from many angles and it’s hard to keep up.…
Advocacy
NYSAM uses its voice and membership to promote public policies that advance addiction medicine and promote access to treatment.
Guidance for NYS Behavioral Health Programs to Prevent the Spread of COVID-19
Department of Health 24/7 Hotline: 1-888-364-3065 The following guidance is based on the most current Centers for Disease Control and…
Public Policy Action: NYSAM A2904/S4808 and A7246B/S5935 Senate Bill Response Letter Regarding Prior Authorization Barriers to Lifesaving Medication Assisted Treatment (MAT).
July 24, 2019 The Honorable Andrew M. Cuomo Governor of New York State NYS State Capitol Building Albany, NY 12224…
ASAM Supports Expansion of Access to Buprenorphine Through The Mainstreaming Addiction Treatment Act
ASAM Board Member, Dr. Margaret Jarvis, testified in front of a Congressional Roundtable on the nation’s response to the “third…
Addiction Medicine Medical Vocabulary
Language Matters We have witnessed remarkable progress in the understanding of the disease of addiction over the past two decades.…
Commentary: Allow Proven Science to Guide Opioid Addiction Treatment
NYSAM board members Dr. Melissa Weimer and Dr. Jeffrey Selzer together with Dr. Daniel Schatz, adjunct assistant professor in the…